Characterization of metabolites of GLS4 in humans using ultrahigh-performance liquid chromatography/quadrupole time-of-flight mass spectrometry

Rapid Communications in Mass Spectrometry

Volumn 27, Issue 21, 2013, Pages 2483-2492

  Zhou, Xin ^a   Li, Liang ^a   Deng, Pan ^a   Chen, Xiaoyan ^a   Zhong, Dafang ^a  

^a SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMOLECULES; DRUG PRODUCTS; IONS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; VIRUSES;

CLINICAL TRIAL; HEPATITIS B VIRUS; HEPATITIS B VIRUS INFECTION; LIQUID CHROMATOGRAPHY-QUADRUPOLE TIME-OF-FLIGHT MASS SPECTROMETRIES; LIQUID CHROMATOGRAPHY/QUADRUPOLE-TIME OF FLIGHT MASS SPECTROMETRIES; MORPHOLINES; NUCLEOCAPSIDS; RAPID METHOD; ULTRA-HIGH PERFORMANCE LIQUID CHROMATOGRAPHIES; VIRUS REPLICATION;

METABOLITES;

ETHYL 4-(2-BROMO-4-FLUOROPHENYL)-6-(MORPHOLINOMETHYL)-2-(2-THIAZOLYL)-1,4-DIHYDROPYRIMIDINE-5-CARBOXYLATE; ANTIVIRUS AGENT; ETHYL 4 (2 BROMO 4 FLUOROPHENYL) 6 (MORPHOLINOMETHYL) 2 (2 THIAZOLYL) 1,4 DIHYDROPYRIMIDINE 5 CARBOXYLATE; PYRIMIDINE DERIVATIVE; THIAZOLE DERIVATIVE;

ARTICLE; CHEMISTRY; HEPATITIS B; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; MASS SPECTROMETRY; METABOLISM;

ANTIVIRAL AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HEPATITIS B; HUMANS; MALE; MASS SPECTROMETRY; PYRIMIDINES; THIAZOLES;

EID: 84885206327     PISSN: 09514198     EISSN: 10970231     Source Type: Journal    
DOI: 10.1002/rcm.6710     Document Type: Article

References (16)

1. Institute of Medicine. Hepatitis and liver cancer: a national strategy for prevention and control of hepatitis B and C. The National Academies Press, Washington, DC, 2010.
2. World Health Organization. Fact Sheet #204: Hepatitis B. 2012 July (cited 2013 May 23). Available: http://www.who.int/mediacentre/factsheets/fs204/en/ index.html.
3. X. Y. Wang, Z. M. Wei, G. Y. Wu, J. H. Wang, Y. J. Zhang, J. Li, H. H. Zhang, X. W. Xie, X. Wang, Z. H. Wang, L. Wei, Y. Wang, H. S. Chen,. In vitro inhibition of HBV replication by a novel compound, GLS4, and its efficacy against adefovir-dipivoxil-resistant HBV mutations. Antivir. Ther. 2012, 17, 793.
4. K. Deres, C. H. Schroder, A. Paessens, S. Goldmann, H. J. Hacker, O. Weber, T. Kramer, U. Niewohner, U. Pleiss, J. Stoltefuss, E. Graef, D. Koletzki, R. N. Masantschek, A. Reimann, R. Jaeger, R. Gross, B. Beckermann, K. H. Schlemmer, D. Haebich, H. Rubsamen-Waigmann,. Inhibition of hepatitis B virus replication by drug-induced depletion of nucleocapsids. Science 2003, 299, 893.
5. D. Liu, J. Jiang, L. Zhang, F. Tan, Y. Wang, P. Hu,. Metabolite characterization of a novel anti-cancer agent, icotinib, in humans through liquid chromatography/quadrupole time-of-flight tandem mass spectrometry. Rapid Commun. Mass Spectrom. 2011, 25, 2131.
6. M. Zhu, W. Zhao, N. Vazquez, J. G. Mitroka,. Analysis of low level radioactive metabolites in biological fluids using high-performance liquid chromatography with microplate scintillation counting: method validation and application. J. Pharm. Biomed. Anal. 2005, 39, 233.
7. H. Z. Bu, P. Kang, P. Zhao, W. F. Pool, E. Y. Wu,. A simple sequential incubation method for deconvoluting the complicated sequential metabolism of capravirine in humans. Drug Metab. Dispos. 2005, 33, 1438.
8. C. Xie, D. Zhong, X. Chen,. Identification of the ortho-benzoquinone intermediate of 5-O-caffeoylquinic acid in vitro and in vivo: comparison of bioactivation under normal and pathological situations. Drug Metab. Dispos. 2012, 40, 1628.
9. P. Deng, T. You, X. Chen, T. Yuan, H. Huang, D. Zhong,. Identification of amiodarone metabolites in human bile by ultraperformance liquid chromatography/quadrupole time-of-flight mass spectrometry. Drug Metab. Dispos. 2011, 39, 1058.
10. J. Ding, X. Chen, Z. Gao, X. Dai, L. Li, C. Xie, H. Jiang, L. Zhang, D. Zhong,. Metabolism and pharmacokinetics of novel selective vascular endothelial growth factor receptor-2 inhibitor apatinib in humans. Drug Metab. Dispos. 2013, 41, 1195.
11. Z. Liu, D. Zhu, L. Lv, Y. Li, X. Dong, Z. Zhu, Y. Chai,. Metabolism profile of timosaponin B-II in urine after oral administration to rats by ultrahigh-performance liquid chromatography/quadrupole-time-of-flight mass spectrometry. Rapid Commun. Mass Spectrom. 2012, 26, 1955.
12. Y. Wang, X. Chen, Q. Li, D. Zhong,. Metabolite identification of arbidol in human urine by the study of CID fragmentation pathways using HPLC coupled with ion trap mass spectrometry. J. Mass Spectrom. 2008, 43, 1099.
13. R. Jauch, R. Hankwitz, D. Maass, R. Wollmann,. The absorption, excretion and metabolic pattern of bromhexine in man after oral and i.v. administration. Arzneimittelforschung 1975, 25, 1954.
14. N. Ishiguro, C. Senda, W. Kishimoto, K. Sakai, Y. Funae, T. Igarashi,. Identification of CYP3A4 as the predominant isoform responsible for the metabolism of ambroxol in human liver microsomes. Xenobiotica 2000, 30, 71.
15. 1H NMR spectroscopy. NMR Biomed. 2006, 19, 90.
16. L. M. Berry, L. Wollenberg, Z. Zhao,. Esterase activities in the blood, liver and intestine of several preclinical species and humans. Drug Metab. Lett. 2009, 3, 70.